Crossmark

Patient risk evaluation for transcatheter aortic valve replacement (PRE-TAVR) — identification of real-time predictors of short- and long-term mortality

Crossref DOI link: https://doi.org/10.1007/s00392-025-02704-6

Published Online: 2025-07-07

Published Print: 2025-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kreutz, Julian https://orcid.org/0000-0001-9498-9558
Lauten, Philipp

Chatzis, Georgios

Nabrotzki, Marie

Patsalis, Nikolaos

Syntila, Styliani

Lapp, Harald

Schieffer, Bernhard

Markus, Birgit
Funding

Funding for this research was provided by:

Philipps-Universität Marburg
License Information

Text and Data Mining valid from 2025-07-07

Version of Record valid from 2025-07-07
More Information

Article History

Received: 8 April 2025

Accepted: 10 June 2025

First Online: 7 July 2025

Declarations

:

: JK, GC, BS, and BM receive speakers’ honoraria from Abiomed; JK and BM received speakers’ honoraria from Astra Zeneca, BS received speakers’ honoraria from Bayer and GSK; BM received research funding from Abiomed; PL receive speakers’ honoraria from Medtronic, Edwards, and Boston plus Shockwave Medical. No other authors reported disclosures.

Document is current

Any future updates will be listed below